Healthcare Sales & Marketing Network News: Sanofi

Searching News Database: Sanofi

HSMN NewsFeed - 1 Aug 2025
BioMarin Announces Appointment of Ian T. Clark to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jun 2025
SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines
Regenerative Medicine Ophthalmology Venture Capital

HSMN NewsFeed - 2 Jun 2025
Sanofi to Acquire Blueprint Medicines, Expanding Portfolio in Rare Immunological Disease and Adding Early-stage Pipeline in Immunology
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 May 2025
Hansa Biopharma appoints Maria Törnsén as Chief Operating Officer and President U.S.
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Mar 2025
Latigo Biotherapeutics Closes $150 Million in Series B Financing to Advance Non-Opioid Pain Therapeutics
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Jun 2024
European Commission grants Sobi(R) Marketing Authorisation for ALTUVOCT(TM) for treatment of haemophilia A
Biopharmaceuticals Regulatory

HSMN NewsFeed - 6 Jun 2024
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 26 Apr 2024
Sobi(R) Receives Positive CHMP Opinion Recommending Approval of Efanesoctocog Alfa for Once-Weekly Treatment of Haemophilia A
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 Sep 2023
Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 May 2023
Endogenex(TM) Appoints Christopher Sorli as Chief Medical Officer
Devices Personnel

HSMN NewsFeed - 9 Mar 2023
QurAlis Closes $88 Million Series B Financing to Advance Precision Medicines for Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 24 Feb 2023
FDA approves once-weekly efanesoctocog alfa, a new class of high-sustained factor VIII therapy for haemophilia A: Swedish Orphan Biovitrum AB
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Dec 2022
Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 21 Oct 2022
Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA(R) (aflibercept) Injection
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 25 Jul 2022
HotSpot Therapeutics Appoints Paul Thibodeau, Ph.D., as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jul 2022
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jun 2022
Rockwell Medical, Inc. Appoints Mark Strobeck, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Feb 2022
Azurity Pharmaceuticals Announces Richard Blackburn as New CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Nov 2021
Ichnos Sciences Appoints Sonia Quaratino, M.D., Ph.D., To Its Board Of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 8 Nov 2021
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 3 Nov 2021
Biond Biologics Announces Closing of $15 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Oct 2021
Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Oct 2021
FDA Expands Approval of Dupixent(R) (dupilumab) to Include Children Aged 6 to 11 Years with Moderate-to-severe Asthma
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Sep 2021
Synlogic Appoints Molly Harper as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Aug 2021
LQT Therapeutics Announces Closing of US$19M Series A Financing to Advance Lead Compound Through Phase 1 while Advancing Portfolio Assets
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 27 Jul 2021
SynOx Therapeutics Strengthens Team with Appointment of Ton Logtenberg as Chairman and Ray Barlow as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 13 Jul 2021
Regulatory Affairs Expert Ana Sousa Joins Aspen Neuroscience as Senior Vice President
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 1 Jul 2021
Windtree Appoints Diane Carman, Esq. as Senior Vice President and General Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jun 2021
Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 1 Jun 2021
Macrophage Pharma Appoints Dr Venkat Reddy as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 May 2021
Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19
Regenerative Medicine Licensing

HSMN NewsFeed - 19 May 2021
LogicBio Therapeutics Promotes Daniel Gruskin, MD, to Chief Medical Officer and Announces Additional Leadership Appointments
Biopharmaceutical Personnel

HSMN NewsFeed - 10 May 2021
LogicBio Therapeutics Strengthens Management Team with Key Appointments
Regenerative Medicine Personnel

HSMN NewsFeed - 25 Feb 2021
Medisafe Secures $30M in Series C Funding to Build Future Model of Patient Support
Devices Venture Capital

HSMN NewsFeed - 12 Feb 2021
The Lancet Publishes Libtayo(R) (cemiplimab) Data Showing Extended Overall Survival in Patients with First-line Advanced Non-small Cell Lung Cancer with PD-L1 Expression of ≥50%
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Jan 2021
DURECT Corporation Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 30 Dec 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals

HSMN NewsFeed - 15 Dec 2020
MinervaX raises upsized EUR 47.4M (USD 57M) Series B to advance its novel Group B Streptococcus vaccine through mid-stage clinical trials
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 29 Oct 2020
Q32 Bio Closes $60 Million Series B Financing, Advances to Clinical Stage Research in Therapeutics Designed to Restore Immune Homeostasis
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Oct 2020
Dewpoint Therapeutics Appoints Ameet Nathwani as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Sep 2020
Novo Ventures co-leads US $83m series C financing in Lava Therapeutics
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 31 Aug 2020
Mylan and Biocon Biologics Announce Launch of Semglee(TM) (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 24 Aug 2020
Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 19 Jun 2020
Dupixent(R) (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 11 Jun 2020
Lannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine, Following FDA Meeting
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 3 Jun 2020
Novo Ventures Leads US$55M Series B Investment in NodThera
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 May 2020
Acquist Therapeutics Announces New Appointments to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 May 2020
Protalix BioTherapeutics Announces Positive Topline Results from the BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals

HSMN NewsFeed - 13 Feb 2020
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
Devices Personnel

HSMN NewsFeed - 3 Feb 2020
Eisai Inc. Expands Leadership Team in the US with the Appointment of Two Key Leaders
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jan 2020
Candel Therapeutics Appoints Sandra E. Poole as Chief Operating Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 9 Jan 2020
enGene Announces Additions to Senior Management Team
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 2 Dec 2019
Orexo Appoints Dennis Urbaniak as Executive Vice President Digital Health
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Nov 2019
Regeneron Provides Updates on Phase 3 Libtayo(R) (cemiplimab) Development Program in Advanced Non-small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Oct 2019
Sanofi to conduct precautionary voluntary recall of Zantac OTC in U.S. and Canada
Biopharmaceuticals Product Recall

HSMN NewsFeed - 22 Aug 2019
Torque Expands Leadership Team with Appointment of Sok Cheng Soh as CFO and Ana Radeljevic as VP, Head of Business Operations
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 6 Aug 2019
Dupixent(R) (dupilumab) Approved by European Commission for Adolescents with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 23 Jul 2019
Proteostasis Therapeutics Announces Management Changes and Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2019
ViaCyte Appoints Sandra E. Poole to Board of Directors
Regenerative Medicine Personnel

HSMN NewsFeed - 11 Jun 2019
GT Apeiron Therapeutics launched by GT Healthcare Capital Partners signs with Exscientia
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Jun 2019
Eiger Appoints Industry Veteran and Regulatory Affairs Expert Mark Mannebach, PhD, RPh as Vice President of Global Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 May 2019
Dupixent(R) (dupilumab) Approved for Severe Asthma by European Commission
Biopharmaceuticals Regulatory

HSMN NewsFeed - 29 Mar 2019
PolarityTE Announces Richard Hague, Formerly from Sanofi, Genzyme and Recently Anika Therapeutics as Chief Operating Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 25 Mar 2019
Inovio Appoints Global Commercial Leader to its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 Mar 2019
CHMP Recommends Approval of Dupixent(R) (dupilumab) for Asthma Indication
Biopharmaceuticals Regulatory

HSMN NewsFeed - 4 Feb 2019
CHMP Recommends Approval of Praluent(R) (alirocumab) Injection to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 20 Dec 2018
Evox Therapeutics Appoints Edwin Moses as Non-Executive Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Dec 2018
Sanofi's Formulation Patents on Multibillion-Dollar Lantus(R) are Invalidated by U.S. Patent and Trademark Office via IPR, Announces Mylan
Biopharmaceuticals Generics Endocrinology Litigation

HSMN NewsFeed - 13 Nov 2018
Kymera Therapeutics Announces $65 Million Series B Financing to Advance Pipeline of Targeted Protein Degraders in Oncology and Immunology
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 13 Nov 2018
Sobi(TM) to Acquire Synagis(R) US Rights From AstraZeneca - Creates a Platform for Global Growth
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 1 Nov 2018
Senhwa Biosciences Silmitasertib filed IND of Basal Cell Carcinoma approved by FDA
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 22 Oct 2018
EpiVax Oncology Appoints Dominique Bridon as Chief Technology Officer and Dan Adams to the Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 22 Oct 2018
FDA Approves Asthma Indication for Dupixent(R) (dupilumab)
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Sep 2018
FDA to Review Supplemental Biologics License Application for Praluent(R) (alirocumab)Injection as Potential Treatment to Reduce Major Adverse Cardiovascular Events
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 4 Sep 2018
Applied Therapeutics Announces Appointment of Riccardo Perfetti, MD, PhD, as Chief Medical Officer
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 3 Sep 2018
Cablivi(TM) (caplacizumab) approved in Europe for adults with acquired thrombotic thrombocytopenic purpura (aTTP)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 14 Aug 2018
Sigilon Therapeutics Announces Leadership Transition and Appoints Rare Disease Pioneer Rogerio Vivaldi, M.D., as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Aug 2018
Actavalon Announces Appointments of Dr. John Hood to Its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 Aug 2018
Oncorus(R), Inc., Names Industry Veteran Ted Ashburn as new President and CEO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 8 Jun 2018
Albireo Elects Anne Klibanski and Stephanie Okey to Board of Directors
Biopharmaceuticals Gastroenterology Personnel

HSMN NewsFeed - 4 Jun 2018
Codiak BioSciences Names Richard Brudnick Chief Business Officer and Head of Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 May 2018
Positive Phase 3 Trial of DUPIXENT(R) (dupilumab) in Adolescents with Inadequately Controlled Moderate-to-severe Atopic Dermatitis
Biopharmaceuticals Dermatology

HSMN NewsFeed - 1 May 2018
Regeneron and Sanofi to Lower Net Price of Praluent(R) (alirocumab) Injection in Exchange for Straightforward, More Affordable Patient Access for Express Scripts Patients
Biopharmaceuticals Reimbursement

HSMN NewsFeed - 30 Apr 2018
Forty Seven Inc. Appoints Ian T. Clark to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 30 Apr 2018
FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 4 Apr 2018
Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2018
FDA approves Toujeo(R) Max SoloStar(R)
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 8 Mar 2018
Sanofi Completes Acquisition of Bioverativ Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 2 Mar 2018
FDA to Review DUPIXENT(R) (dupilumab) as Potential Treatment for Moderate-to-Severe Asthma
Biopharmaceuticals FDA

HSMN NewsFeed - 31 Jan 2018
Boehringer Ingelheim Announces Paul Fonteyne to Retire at the end of 2018. Wolfgang Baiker Appointed U.S. President & CEO Effective March 1, 2018
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jan 2018
Regeneron Announces Approval of DUPIXENT(R) (dupilumab) in Japan for the Treatment of Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 14 Dec 2017
Mylan Announces the U.S. Patent and Trademark Appeal Board Institutes Inter Partes Review Proceedings on All Claims Against Sanofi's Lantus(R) Patents
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 1 Dec 2017
EMD Serono Appoints Zhen Su, M.D., MBA to Chief Medical Officer, North America
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Oct 2017
Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development
Devices Regenerative Medicine Personnel

HSMN NewsFeed - 28 Sep 2017
Regeneron and Sanofi Announce Approval of DUPIXENT(R) (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis in the European Union
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 8 Sep 2017
Regeneron and Sanofi Announce Cemiplimab (REGN2810) Has Received FDA Breakthrough Therapy Designation for Advanced Cutaneous Squamous Cell Carcinoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 25 Aug 2017
Regeneron and Sanofi to Present New Analyses from Praluent(R) (alirocumab) Injection Trials at the ESC Congress 2017
Biopharmaceuticals Cardiology

HSMN NewsFeed - 15 Aug 2017
Lexicon Pharmaceuticals Reports Additional Positive Data From Pivotal Phase 3 inTandem2 Study Of Sotagliflozin
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 14 Aug 2017
Regeneron to Discontinue Development of Suptavumab for Respiratory Syncytial Virus
Biopharmaceuticals

HSMN NewsFeed - 14 Aug 2017
Merrimack Augments Executive Team with Appointment of Jean Franchi as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jun 2017
Lexicon Pharmaceuticals Reports Positive Top-Line Results In Phase 3 inTandem3 Study For Sotagliflozin In Patients With Type 1 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 19 May 2017
Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 May 2017
Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Apr 2017
Regeneron and Sanofi Announce Kevzara(R) (sarilumab) Biologics License Application Resubmission Accepted for Review by U.S. FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Apr 2017
Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent(R) (alirocumab) Injection
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 24 Apr 2017
Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara(R) (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 10 Apr 2017
Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
Regenerative Medicine Personnel

HSMN NewsFeed - 28 Mar 2017
Sanofi and Regeneron Announce FDA Approval of Dupixent(R) (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 6 Mar 2017
BrainStorm Strengthens Management Team with Appointment of Ralph Z. Kern, MD, MHSc as Chief Operating Officer and Chief Medical Officer
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 28 Feb 2017
Kevzara(TM) (sarilumab) now available in Canada for the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis
Biopharmaceuticals Product Launch

HSMN NewsFeed - 9 Feb 2017
Appeals Court Grants Stay of Permanent Injunction for Praluent(R) (alirocumab) During Appeals Process
Biopharmaceuticals Cardiology Litigation

HSMN NewsFeed - 1 Feb 2017
Sanofi Appoints Hugo Fry as General Manager UK
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Jan 2017
Verastem Announces Executive Leadership Appointments and Changes
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 18 Jan 2017
Merrimack Names Richard Peters, M.D., Ph.D., as President and CEO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 6 Jan 2017
Regeneron and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent(R) (alirocumab) Injection
Biopharmaceuticals Cardiology Litigation

HSMN NewsFeed - 4 Jan 2017
Corvus Pharmaceuticals Names Ian T. Clark, Former Genentech Chief Executive Officer, to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jan 2017
Agios Appoints Ian Clark to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 8 Dec 2016
Regeneron and Sanofi Announce Marketing Authorization Application for Dupixent(R) (dupilumab) Accepted for Review by the EMA
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 22 Nov 2016
Groundbreaking Team At Aquinnah Pharmaceuticals Adds Two New Members To Help Overcome The Challenge Of ALS And Alzheimer's Disease
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 17 Nov 2016
Regeneron and Sanofi Announce Praluent(R) (alirocumab) Cardiovascular Outcomes Trial Will Continue as Planned Following Interim Analysis
Biopharmaceuticals

HSMN NewsFeed - 15 Nov 2016
Blueprint Medicines Announces Appointment of Marion Dorsch, Ph.D. as Chief Scientific Officer and the Transition of Christoph Lengauer, Ph.D., MBA, to a Newly Created Executive Vice President Role
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Oct 2016
Launch of Carrick Therapeutics Signals New Approach to Cancer Therapies
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 26 Sep 2016
Regeneron and Sanofi Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 12 Sep 2016
Sanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 7 Sep 2016
AMAG Pharmaceuticals Appoints Tony Casciano as Senior Vice President of Hematology/Oncology Sales and Marketing
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 29 Aug 2016
Regeneron and Sanofi Present Positive Phase 3 Investigational Data for Praluent(R) (alirocumab) Injection in Patients Undergoing LDL Apheresis Therapy at ESC Congress 2016
Biopharmaceuticals Cardiology

HSMN NewsFeed - 21 Jul 2016
ProMIS Neurosciences Announces Appointment of Dr. Johanne Kaplan as Chief Development Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 20 Jul 2016
Cellectar Biosciences Appoints Jarrod Longcor Senior Vice President of Corporate Development and Operations
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 5 Jul 2016
Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 20 Jun 2016
Regulus Secures $30 Million Growth Capital Credit Facility
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 1 Apr 2016
Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients
Biopharmaceuticals Dermatology

HSMN NewsFeed - 15 Mar 2016
CoLucid Pharmaceuticals Announces Election of Alison Lawton to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Mar 2016
Regeneron and Sanofi Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 3 Mar 2016
Lumira Capital Announces Expansion of Investment Team with Appointment of Three Venture Partners
Devices Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 25 Feb 2016
Valeritas Announces Leadership and Board of Directors Changes
Devices Endocrinology Personnel

HSMN NewsFeed - 1 Feb 2016
Merial Appoints Susan Sholtis as President, North America
Biopharmaceuticals Veterinary Personnel

HSMN NewsFeed - 8 Jan 2016
NewLink Genetics Corporation Appoints Brian Wiley as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 24 Dec 2015
Eagle Pharmaceuticals Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 3 Nov 2015
CureVac raises $110 Million in a private placement
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 30 Oct 2015
Regeneron Announces EU Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 29 Oct 2015
Anika Appoints Richard Hague to Role of Chief Commercial Officer
Devices Orthopaedic Personnel

HSMN NewsFeed - 19 Oct 2015
Sorrento Expands its Executive Management Team with Appointment of Dr. Jeffrey Su as Chief Operating Officer to Lead its in-house Bioprocess and Manufacturing Operations
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 5 Oct 2015
Egalet Appoints Mark Strobeck, Ph.D. to Executive Vice President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Sep 2015
Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in the European Union
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 25 Aug 2015
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jul 2015
Regeneron and Sanofi Announce FDA Approval of Praluent(R) (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 24 Jul 2015
Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 Jul 2015
Wilson Therapeutics Announces the Appointment of Dr. Carl Bjartmar as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jul 2015
Voyager Therapeutics Appoints Michael Higgins to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 15 Jul 2015
Histogenics Corporation Announces Dr. Gloria Matthews as Chief Medical Officer
Devices Regenerative Medicine Orthopaedic Personnel

HSMN NewsFeed - 26 Jun 2015
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 8 Jun 2015
Alnylam Appoints David-Alexandre Gros, M.D., Senior Vice President, Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 May 2015
Zafgen Appoints Global Head of Medical Affairs and Global Head of Regulatory
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 May 2015
Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Studies with Sarilumab in Patients with Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 16 Mar 2015
Moderna Appoints Tal Zaks, Former Head of Sanofi Global Oncology, as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 4 Mar 2015
CASI Pharmaceuticals Appoints Rong Chen, MD, Ph.D. As Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Feb 2015
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 26 Jan 2015
Regeneron and Sanofi Announce Praluent(TM) (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Jan 2015
MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Hakan Edstrom Appointed to CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2014
Sanofi Pasteur Announces FDA Approval of Fluzone(R) Intradermal Quadrivalent (Influenza Vaccine) for Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Dec 2014
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 18 Nov 2014
Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Oct 2014
Elite Pharmaceuticals Announces New Management Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Oct 2014
EYLEA(R) (aflibercept) Injection Demonstrates Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab in NIH-Sponsored Diabetic Macular Edema Study
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 15 Oct 2014
Portal Instruments Completes Landmark $11 Million Series A Financing to Develop Innovative Drug Delivery Platform
Devices Drug Delivery Venture Capital

HSMN NewsFeed - 22 Sep 2014
Regeneron Announces EYLEA(R) (aflibercept) Injection Approved for the Treatment of Patients with Myopic Choroidal Neovascularization (CNV) in Japan
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 11 Aug 2014
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin
Biopharmaceuticals Endocrinology Drug Delivery Licensing

HSMN NewsFeed - 11 Aug 2014
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 6 Aug 2014
Synta Names Anne Whitaker Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Aug 2014
Akebia Therapeutics Announces Expansion of Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jul 2014
Alnylam Elects Amy Schulman to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2014
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 16 Jun 2014
Regulus Appoints Paul C. Grint, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jun 2014
Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business
Regenerative Medicine

HSMN NewsFeed - 14 May 2014
POZEN Announces U.S. Rights for Treximet(R) to Be Acquired by Pernix Therapeutics
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 7 Apr 2014
Genzyme to Resubmit Lemtrada(TM) Application for FDA Review
Biopharmaceuticals Neurology

HSMN NewsFeed - 21 Mar 2014
Genzyme’s Lemtrada(TM) Approved in Brazil for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 12 Mar 2014
Mike Sullivan named President of Avion Pharmaceuticals, LLC
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 10 Feb 2014
Two-Year Results From Phase 3 VISTA Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 31 Jan 2014
Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit
Biopharmaceuticals Endocrinology Litigation

HSMN NewsFeed - 21 Jan 2014
Keryx Biopharmaceuticals Announces Appointment of Daniel W. Olmstead as Vice President, Payer Access
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jan 2014
Genzyme and Alnylam Expand Collaboration on Rare Genetic Diseases
Biopharmaceuticals Licensing

HSMN NewsFeed - 13 Jan 2014
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Jan 2014
KaloBios Appoints Harry Lam, Ph.D. as Head of Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Dec 2013
Genzyme Receives Complete Response Letter from FDA on Lemtrada(TM) (alemtuzumab) Application
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 19 Dec 2013
Genzyme’s Lemtrada(TM) Approved in Australia for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 18 Dec 2013
Regeneron Announces FDA Acceptance of EYLEA(R) (aflibercept) Injection Supplemental Biologics License Application for Review for Diabetic Macular Edema Indication
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 13 Dec 2013
Genzyme’s Lemtrada(TM) Approved in Canada for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 12 Dec 2013
Momenta Pharmaceuticals Appoints Michael Franken, M.D. as President, Biosimilars Business
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2013
VIVUS Announces License and Commercialization Agreement With Sanofi for Avanafil in Africa, Middle East, Turkey and CIS/Russia
Biopharmaceuticals Licensing

HSMN NewsFeed - 11 Dec 2013
FDA Grants Priority Review for Genzyme’s Cerdelga(TM) (eliglustat), an Investigational Oral Therapy for Gaucher Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Dec 2013
Tyrosine Pharma Names Laslie President and CEO
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 25 Nov 2013
Pixium Vision raises €15 million led by Sofinnova Partners
Devices Ophthalmology Venture Capital

HSMN NewsFeed - 22 Nov 2013
EYLEA(R) (aflibercept) Injection Approved For The Treatment of Macular Edema Following Central Retinal Vein Occlusion In Japan
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 22 Nov 2013
Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial
Biopharmaceuticals

HSMN NewsFeed - 20 Nov 2013
Health Canada Approves Genzyme's AUBAGIO(R) (teriflunomide), a Once-Daily, Oral Treatment for Relapsing Remitting Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 30 Oct 2013
Immune Design Raises Up to $49 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 28 Oct 2013
Arcturus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Oct 2013
Mallinckrodt Pharmaceuticals Announces Executive Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Oct 2013
OncoMed Pharmaceuticals Appoints Michael Wyzga to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 3 Oct 2013
Aubagio(R) Significantly Reduced Risk of New Clinical Relapse or MRI Lesion in Multiple Sclerosis Study
Biopharmaceuticals Neurology

HSMN NewsFeed - 17 Sep 2013
European Commission Approves Genzyme’s Multiple Sclerosis Treatment Lemtrada(TM) (alemtuzumab)
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 7 Aug 2013
KaloBios Appoints V. Bryan Lawlis, Jr., Ph.D. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jul 2013
Edimer Secures $18M Series B Financing Led by New Enterprise Associates
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 26 Jul 2013
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion in Europe
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 17 Jul 2013
Intarcia Therapeutics Appoints Dr. Eddie Li Vice President and Global Head of Regulatory Affairs
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 10 Jul 2013
Idera Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jul 2013
Arch Therapeutics Appoints Senior Management Team Members
Devices Surgery Personnel

HSMN NewsFeed - 2 Jul 2013
Warp Drive Bio Appoints Co-Founder Gregory Verdine, Ph.D., to Chief Executive Officer; Expands Team with Two Key Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jun 2013
Genzyme Receives Positive CHMP Opinion for LEMTRADA(TM) (alemtuzumab) in Europe
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 15 May 2013
Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
Biopharmaceuticals

HSMN NewsFeed - 30 Apr 2013
Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Apr 2013
Teva Establishes Global Specialty Medicines Group
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Apr 2013
Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
Diagnostics Personnel

HSMN NewsFeed - 22 Mar 2013
SciClone Appoints Hong Zhao as Chief Executive Officer, China Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Feb 2013
Regeneron and Bayer Initiate Phase 3 Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 15 Feb 2013
Genzyme Announces Positive New Data from Two Phase 3 Studies for Oral Eliglustat Tartrate for Gaucher Disease
Biopharmaceuticals

HSMN NewsFeed - 5 Feb 2013
ZALTRAP(R) (ziv-aflibercept) Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 4 Feb 2013
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
Regenerative Medicine Mergers & Acquisitions

HSMN NewsFeed - 29 Jan 2013
Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
Devices Surgery Product Launch

HSMN NewsFeed - 28 Jan 2013
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 14 Jan 2013
SciClone Announces Appointment of Simon Li to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jan 2013
Celator(R) Pharmaceuticals Announces Appointment of Lisa DeLuca as Vice President, Regulatory Affairs
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 6 Dec 2012
EYLEA(R) (aflibercept) Submitted for EU Marketing Authorization for the Treatment of Macular Edema Following Central Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 27 Nov 2012
Kala Pharmaceuticals Appoints Dr. Bernard Gilly to Its Board of Directors
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 27 Nov 2012
Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Nov 2012
EYLEA(R) (aflibercept) Injection Approved for the Treatment of Wet Age-Related Macular Degeneration in Europe
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 3 Oct 2012
Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement
Biopharmaceuticals

HSMN NewsFeed - 28 Sep 2012
Osiris Therapeutics Regains Worldwide Rights to Prochymal and Chondrogen
Regenerative Medicine

HSMN NewsFeed - 24 Sep 2012
QLT Announces Sale of Visudyne(R) to Valeant Pharmaceuticals
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 4 Sep 2012
Two New Executives Join VaxInnate Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Sep 2012
Impax Laboratories Announces Settlement of Litigation Relating to RENVELA(R) and RENAGEL(R)
Biopharmaceuticals Litigation

HSMN NewsFeed - 15 Aug 2012
Astellas Pharma Europe Ltd. Appoints Dr Susan Wood as Senior Director, Market Access
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Aug 2012
Sanofi Announces FDA Approval for Auvi-Q(TM), First Voice-guided Epinephrine Auto-injector for Patients with Life-threatening Allergies
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 9 Aug 2012
Hospira Announces U.S. Re-Launch Of Generic Oxaliplatin Injection
Biopharmaceuticals Generics Oncology

HSMN NewsFeed - 20 Jul 2012
Supernus Appoints Dr. Stefan Schwabe, MD, PhD as Exec. VP R&D and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jul 2012
Sanofi Biosurgery Product MACI(R) Demonstrates Statistically Significant Clinical Outcomes Compared to Microfracture
Devices Orthopaedic

HSMN NewsFeed - 12 Jul 2012
Kala Pharmaceuticals Appoints Guillaume Pfefer, PhD as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jul 2012
Jeff Cooper Joins KaloBios as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2012
Alnylam Expands and Develops Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jun 2012
EMD Serono, Inc. Strengthens Leadership Teams with New Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jun 2012
Genzyme Submits Applications to FDA and EMA for Approval of LEMTRADA(TM) (alemtuzumab) for Multiple Sclerosis
Biopharmaceuticals Neurology FDA Regulatory

HSMN NewsFeed - 1 Jun 2012
Genzyme Reports Positive Top-Line Results of TOWER, a Pivotal Phase III Trial for AUBAGIO(TM)* (teriflunomide) in Relapsing Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 7 Apr 2012
SciClone Announces Board of Directors and Officer Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Apr 2012
Richard T. Kloos, M.D., Joins Veracyte as Senior Medical Director
Diagnostics Personnel

HSMN NewsFeed - 5 Apr 2012
Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP(R) (aflibercept)
Biopharmaceuticals

HSMN NewsFeed - 2 Apr 2012
NicOx appoints Philippe Masquida EVP, Managing Director of European Operations ; Next step in the Company's strategy to create an international ophthalmology company
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 28 Mar 2012
Raptor Pharmaceutical Corp. Announces the Appointment of Henk Doude van Troostwijk as General Manager of European Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Mar 2012
ImmusanT Names Patrick Griffin as Chief Medical Officer, Expands Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Mar 2012
QLT Receives Orphan Drug Designation for Visudyne for Treatment of Central Serous Chorioretinopathy
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 16 Mar 2012
Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery
Devices Surgery Mergers & Acquisitions

HSMN NewsFeed - 20 Jan 2012
Genzyme and Veracyte Announce Global Co-Promotion Agreement to Deliver Personalized Solution for Thyroid Patients
Diagnostics Endocrinology Oncology Personalized Medicine

HSMN NewsFeed - 3 Jan 2012
Regeneron Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA(TM) (aflibercept) Injection
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 22 Dec 2011
Dr. Rob Koremans to succeed Dr. Gerard van Odijk as President and CEO of Teva Europe
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Dec 2011
Valeant Pharmaceuticals Completes Acquisition of Dermik
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 5 Dec 2011
Radius Transitions Company Leadership; Names Michael Wyzga President and Chief Executive Officer to Advance Phase 3 Osteoporosis Drug and Drive Corporate Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Nov 2011
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA(TM*)) in Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 Oct 2011
Acton Pharmaceuticals, Inc. Announces License Agreement with Sanofi U.S. for NASACORT HFA(TM) (triamcinolone acetonide) Nasal Aerosol
Biopharmaceuticals Licensing

HSMN NewsFeed - 11 Oct 2011
Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Sep 2011
Theracrine Appoints Steven Kelly as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jul 2011
Genzyme and Isis Announce Submission of European Marketing Authorization Application for Mipomersen (Kynamro(R))
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 Jul 2011
New Senior Executives Appointed at Sanofi
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jul 2011
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada(TM)*) in Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 Jul 2011
Valeant Pharmaceuticals Agrees to Acquire Dermik
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 22 Jun 2011
Geoffrey McDonough appointed President and CEO of Sobi
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jun 2011
ZALTRAP (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Jun 2011
Esperance Pharmaceuticals Completes $7.5 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 3 May 2011
Optimer Pharmaceuticals Expands Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Mar 2011
KaloBios Announces Two Significant Additions to Its Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Jan 2011
Genzyme Will Allow sanofi-aventis to Conduct Due Diligence
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 20 Dec 2010
NovaDigm Therapeutics Appoints C. Boyd Clarke to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Sep 2010
AVEO Pharmaceuticals, Inc. Appoints Michael P. Bailey to the Newly Created Position of Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Aug 2010
Genzyme Confirms Receipt of Unsolicited Proposal
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Aug 2010
Data from First Phase 3 Trial (EDEMA3(R)) for KALBITOR(R) (ecallantide) Published in The New England Journal of Medicine
Biopharmaceuticals

HSMN NewsFeed - 1 Jul 2010
BioVex Appoints Steven Kelly as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Mar 2010
Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jan 2010
IRX Therapeutics Appoints Neil L. Berinstein Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Aug 2009
Mylan Begins Marketing First Generic Version of BenzaClin(R) Acne Treatment
Biopharmaceuticals Generics Dermatology

HSMN NewsFeed - 3 Aug 2009
Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 18 Jun 2009
Hospira Receives Favorable Court Decision on Eloxatin(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 13 May 2009
Molecular Insight Pharmaceuticals Expands Management Team by Appointing Daniel L. Peters as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Apr 2009
Abraxis BioScience Names Lonnie Moulder President and Chief Executive Officer; Soon-Shiong Remains Executive Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Apr 2009
Cohera Medical Names William M. Cotter as Company's First Vice President of Manufacturing
Devices Wound Care Personnel

HSMN NewsFeed - 11 Feb 2009
Jean-Pierre Lehner Appointed Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Feb 2009
Laurence Debroux Appointed Chief Strategic Officer (CSO)
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Feb 2009
Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 22 Dec 2008
Biovail Enters into Commercial Alliance for Aplenzin
Biopharmaceuticals Distribution

HSMN NewsFeed - 22 Oct 2008
Mylan Receives Tentative FDA Approval for First-to-File Generic Version of Blood Pressure Drug Benicar HCT(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 13 Oct 2008
Cordis Announces New Leadership Positions in Key Business Groups
Devices Cardiology Personnel

HSMN NewsFeed - 4 Sep 2008
Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients with Diabetes and Multi-Vessel Disease
Devices Interventional Cardiology

HSMN NewsFeed - 7 Jul 2008
A.P. Pharma Appoints Ronald J. Prentki as President, Chief Executive Officer and Member of Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jun 2008
FDA Approves KINRIX(TM) - New Combination Vaccine for Children
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jun 2008
Mylan Announces Tentative FDA Approval for Generic Version of Antihypertensive Avalide(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 29 May 2008
Biogen Idec Names Hans Peter Hasler Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Mar 2008
Pharming signs distribution agreement for Rhucin(R) in Turkey
Biopharmaceuticals Distribution

HSMN NewsFeed - 7 Mar 2008
FDA Approves New Drug Application (NDA) for LEVOleucovorin, Spectrum's First Proprietary Oncology Drug
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 7 Mar 2008
Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel
Biopharmaceuticals Licensing Oncology

HSMN NewsFeed - 4 Feb 2008
Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jan 2008
Steve Glass Appointed Vice President and General Manager, BioMarin Europe, Ltd.
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jan 2008
Dr. Manuel Worcel Appointed CEO and President of Cardiokine
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Oct 2007
Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Oct 2007
Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Sep 2007
MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
Biopharmaceuticals Licensing

HSMN NewsFeed - 19 Sep 2007
New Data Show That GlaxoSmithKline's Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
Biopharmaceuticals

HSMN NewsFeed - 10 Sep 2007
Crucell Appoints Mr. Cees de Jong as Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Aug 2007
Theratechnologies Appoints Dr. Pierre Caudrelier as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jul 2007
Agensys Raises $41 Million
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 6 Jun 2007
Two Significant Hires Round-Out VaxInnate's Core Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jun 2007
Oxford Biomedica and Sanofi-Aventis Report new TroVax(R) Phase II Trial Results in Renal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Jun 2007
Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 May 2007
Bristol-Myers Squibb Pleads Guilty to Lying to the Federal Government About Deal Involving Blood-Thinning Drug
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 17 May 2007
FDA Advisory Committee Unanimously Votes in Favor of Acambis' Smallpox Vaccine
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Apr 2007
Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 17 Apr 2007
FDA Licenses First U.S. Vaccine for Humans Against Avian Influenza
Biopharmaceuticals Licensing

HSMN NewsFeed - 14 Mar 2007
Novavax Appoints James Robinson Vice President of Technical and Quality Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Mar 2007
Novavax Board of Directors Elect John Lambert as Executive Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Feb 2007
Phase 2 Results of Genasense(R) Plus Chemotherapy in Advanced Prostate Cancer Reported at Cancer Conference
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Feb 2007
Spectrum Pharmaceuticals Announces Satraplatin Data Presentation at the American Society of Clinical Oncology Prostate Cancer Symposium
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Feb 2007
Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc.
Biopharmaceuticals Regenerative Medicine Licensing

HSMN NewsFeed - 1 Feb 2007
VioQuest Pharmaceuticals, Inc. Announces Appointment of Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jan 2007
Seattle Genetics and Agensys Announce Collaboration to Co-Develop and Commercialize Antibody-Drug Conjugate Therapies for Cancer
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Dec 2006
Sanofi pasteur Influenza Vaccine Production Tops 170 Million Doses in 2006
Biopharmaceuticals

HSMN NewsFeed - 11 Dec 2006
Abraxis BioScience to Present Data from Six Studies at San Antonio Breast Cancer Symposium
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Nov 2006
Artes Medical Names Diane S. Goostree President and Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 21 Nov 2006
Intradigm Announces Significant Enhancements of the Company Capabilities, a New Series A Financing and Important Addition to Senior Management Team
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 30 Oct 2006
EyeGate Pharma Starts U.S. Operations in Waltham, MA
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 26 Oct 2006
Kosan Appoints Robert De Jager as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 12 Oct 2006
Micromet, Inc. Expands Management and Appoints Christopher P. Schnittker as Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Oct 2006
Important safety information about KETEK (telithromycin)
Biopharmaceuticals

HSMN NewsFeed - 22 Sep 2006
European Commission Approves GARDASIL(R), Merck's Cervical Cancer Vaccine
Biopharmaceuticals Regulatory

HSMN NewsFeed - 19 Sep 2006
Dermik Laboratories Announces FDA Acceptance of Supplemental Filing Application for Sculptra(R)
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 12 Sep 2006
John Timberlake Joins Valeritas from sanofi-aventis as Executive Vice President and General Manager of Metabolics
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Sep 2006
Catalyst Pharmaceutical Partners, Inc. Appoints Chief Medical Officer and Vice President of Regulatory Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Sep 2006
The New England Journal of Medicine Publishes the STEEPLE Study Which Demonstrated Superior Safety Profile of LOVENOX(R)(Enoxaparin Sodium Injection) Vs. Unfractionated Heparin in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention (PCI)
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 23 Jun 2006
Positive Synvisc Data Presented at European Conference
Biopharmaceuticals

HSMN NewsFeed - 25 May 2006
Abraxis BioScience Bolsters Manufacturing and Global Operational Expertise With Key Senior Executives
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 May 2006
Novavax Strengthens Vaccine Development Team with Two New Appointments
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 85

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 85 additional stories matching:
Sanofi
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.